ID22911A - NEW TRIAZOL DISTRICTS, THE PROCESS OF MAKING AND THE PHARMACY COMPOSITION CONTAINING IT - Google Patents

NEW TRIAZOL DISTRICTS, THE PROCESS OF MAKING AND THE PHARMACY COMPOSITION CONTAINING IT

Info

Publication number
ID22911A
ID22911A IDW991374A ID991374A ID22911A ID 22911 A ID22911 A ID 22911A ID W991374 A IDW991374 A ID W991374A ID 991374 A ID991374 A ID 991374A ID 22911 A ID22911 A ID 22911A
Authority
ID
Indonesia
Prior art keywords
districts
making
composition containing
pharmacy composition
triazol
Prior art date
Application number
IDW991374A
Other languages
Indonesian (id)
Inventor
Eric Bignon
Jean-Pierre Bras
Paul De Cointet
Pierre Despeyroux
Daniel Frehel
Danielle Gully
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of ID22911A publication Critical patent/ID22911A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
IDW991374A 1997-05-13 1998-05-06 NEW TRIAZOL DISTRICTS, THE PROCESS OF MAKING AND THE PHARMACY COMPOSITION CONTAINING IT ID22911A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9705850A FR2763337B1 (en) 1997-05-13 1997-05-13 NOVEL TRIAZOLE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (1)

Publication Number Publication Date
ID22911A true ID22911A (en) 1999-12-16

Family

ID=9506830

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991374A ID22911A (en) 1997-05-13 1998-05-06 NEW TRIAZOL DISTRICTS, THE PROCESS OF MAKING AND THE PHARMACY COMPOSITION CONTAINING IT

Country Status (35)

Country Link
EP (1) EP0984960B1 (en)
JP (1) JP2001524980A (en)
KR (1) KR20010012541A (en)
CN (1) CN1263528A (en)
AR (1) AR011729A1 (en)
AT (1) ATE232207T1 (en)
AU (1) AU725530B2 (en)
BR (1) BR9811465A (en)
CA (1) CA2289573A1 (en)
CO (1) CO4940485A1 (en)
CZ (1) CZ289484B6 (en)
DE (1) DE69811223T2 (en)
DK (1) DK0984960T3 (en)
DZ (1) DZ2486A1 (en)
EE (1) EE9900524A (en)
ES (1) ES2190081T3 (en)
FR (1) FR2763337B1 (en)
GT (1) GT199800068A (en)
HR (1) HRP980258B1 (en)
HU (1) HUP0002763A3 (en)
ID (1) ID22911A (en)
IL (1) IL132903A0 (en)
IS (1) IS5235A (en)
NO (1) NO995513L (en)
NZ (1) NZ500637A (en)
PL (1) PL336772A1 (en)
RU (1) RU2175323C2 (en)
SI (1) SI0984960T1 (en)
SK (1) SK154299A3 (en)
TR (1) TR199902795T2 (en)
TW (1) TW396155B (en)
UY (1) UY24997A1 (en)
WO (1) WO1998051686A1 (en)
YU (1) YU57999A (en)
ZA (1) ZA983997B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802530B1 (en) * 1999-12-17 2002-02-22 Sanofi Synthelabo NOVEL BRANCHED SUBSTITUTED AMINO DERIVATIVES OF 3-AMINO-1-PHENYL-1H [1,2,4] TRIAZOLE, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2815963B1 (en) * 2000-10-26 2003-02-28 Sanofi Synthelabo NOVEL TRIAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PL365328A1 (en) * 2000-10-26 2004-12-27 Sanofi-Synthelabo Triazole derivatives and pharmaceutical compositions comprising them
HUP0004741A2 (en) * 2000-11-28 2002-12-28 Sanofi-Synthelabo Chemical process for the preparation of thiazole derivatives and new intermediate
US20050014805A1 (en) * 2001-10-12 2005-01-20 Chenzhi Zhang Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
EP1314733A1 (en) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
EP1479677A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH New indole derivatives as factor xa inhibitors
EP1532980A1 (en) 2003-11-24 2005-05-25 Novo Nordisk A/S N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
JP2010516768A (en) * 2007-01-26 2010-05-20 メルク・シャープ・エンド・ドーム・コーポレイション Substituted aminopyrimidines as cholecystokinin-1 receptor modulators
EP2548618A3 (en) * 2008-07-15 2013-02-27 Novartis AG Heteroaryl derivatives as DGAT1 inhibitors
CN102414207B (en) * 2009-06-09 2015-09-30 埃科特莱茵药品有限公司 Fluorinated aminotriazole derivatives
WO2011048177A1 (en) * 2009-10-22 2011-04-28 Henkel Ag & Co. Kgaa Agent for temporarily styling keratin-containing fibres, containing a non-ionic starch modified by propylene oxide and a chitosane
CN106928147A (en) * 2017-03-14 2017-07-07 华东师范大学 Tricyclic diterpene analog and preparation method thereof and its application in antiprostate cancer is prepared
CN107271623A (en) * 2017-07-27 2017-10-20 青岛啤酒股份有限公司 Beer potableness evaluation method based on human body satiety
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701708B1 (en) * 1993-02-19 1995-05-19 Sanofi Elf Polysubstituted 2-amido-4-phenylthiazole derivatives, process for their preparation, pharmaceutical composition and use of these derivatives for the preparation of a medicament.
FR2703995B1 (en) * 1993-04-16 1995-07-21 Sanofi Elf 5-ACYLAMINO 1,2,4-THIADIAZOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
TR199902795T2 (en) 2000-02-21
GT199800068A (en) 1999-11-11
YU57999A (en) 2002-06-19
IL132903A0 (en) 2001-03-19
CZ400699A3 (en) 2000-02-16
CN1263528A (en) 2000-08-16
NO995513L (en) 2000-01-12
FR2763337A1 (en) 1998-11-20
DE69811223T2 (en) 2003-11-27
NO995513D0 (en) 1999-11-11
UY24997A1 (en) 2000-10-31
TW396155B (en) 2000-07-01
WO1998051686A1 (en) 1998-11-19
PL336772A1 (en) 2000-07-17
HRP980258B1 (en) 2002-08-31
NZ500637A (en) 2000-11-24
CZ289484B6 (en) 2002-01-16
HUP0002763A2 (en) 2001-06-28
ATE232207T1 (en) 2003-02-15
SK154299A3 (en) 2000-05-16
FR2763337B1 (en) 1999-08-20
JP2001524980A (en) 2001-12-04
DK0984960T3 (en) 2003-05-26
DZ2486A1 (en) 2003-02-01
CO4940485A1 (en) 2000-07-24
IS5235A (en) 1999-10-29
ES2190081T3 (en) 2003-07-16
AU725530B2 (en) 2000-10-12
EP0984960B1 (en) 2003-02-05
BR9811465A (en) 2000-09-12
EP0984960A1 (en) 2000-03-15
HRP980258A2 (en) 1999-02-28
AU7659998A (en) 1998-12-08
CA2289573A1 (en) 1998-11-19
AR011729A1 (en) 2000-08-30
RU2175323C2 (en) 2001-10-27
DE69811223D1 (en) 2003-03-13
EE9900524A (en) 2000-06-15
HUP0002763A3 (en) 2002-05-28
ZA983997B (en) 1999-11-12
KR20010012541A (en) 2001-02-15
SI0984960T1 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
ID24929A (en) DURUNAN 2-ARIL-8-OXYODIHYDRROPURIN, THE PROCESS OF MAKING IT, THE COMPOSITION OF THE PHARMACY THAT CONTAINS IT, AND ITS COMPOUND
ID30299A (en) OKSAZOLIDINON DERIVES, THE PROCESS OF MAKING IT AND THE PHARMACY COMPOSITION THAT CONTAINS IT
ID26399A (en) DEGREE 1- (1-SUBSTITUTED-4-PIPERIDINYL) METHYL-4-PIPERIDIN, THE PROCESS OF MAKING, PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPOUNDS, AND THEIR INTERMEDIETY
ID19290A (en) PROPIOFENON DECREASES AND THE PROCESS OF MAKING
ID17307A (en) ORAL COMPOSITION AND THE PROCESS OF MAKING.
ID16128A (en) NEW ARILGLICINAMIDE DEPOSITS, THE PROCESS OF MAKING AND PHARMACY COMPOSITION THAT CONTAINS THIS COMPOUND
ID22821A (en) SULFONAMIDA DERIVES, THE PROCESS OF MAKING AND USING IT AS A MEDICINE
ID26207A (en) SUBSTITUTED ESTRATRIENA 11β-HALOGEN-7 αTERSUBSTITUTATION, PROCESS FOR PRODUCING PHARMACEUTICAL PROPERTIES CONTAINING ESTRATRIENA 11β-HALOGEN-7 αINII AND ALSO USE FOR PHARMACEUTICAL PRODUCTION CONTAINING
ID15947A (en) PHENOL COMPOUNDS AND THE PROCESS OF MAKING IT
ID25543A (en) ALPHA-ARIL-N-ALKINITRON AND THE PHARMACY COMPOSITION CONTAINING IT
ID25469A (en) STORIES OF CHRISTALOGRAPHY AND THE PROCESS OF MAKING AMORF SEFALOSPORINE
ID26589A (en) 4-HALOALKYL -3-HETEROSICLYLPIRIDINE AND 4- HALOALKYL-5-HETEROSICLYLPIRIMIDINE PROCESS FOR THE MAKING OF A COMPOSITION CONSTITUTING OF IT AND THE USE OF IT AS A PESTICIDE
ID21045A (en) MODIFIED AMINO ACID, THE DRUGS CONTAINING THIS COMPOUND AND THE PROCESS OF MAKING IT
ID22911A (en) NEW TRIAZOL DISTRICTS, THE PROCESS OF MAKING AND THE PHARMACY COMPOSITION CONTAINING IT
ID20604A (en) SYNTHETIC POLICAKARIDA PROCESS FOR THE MAKING AND COMPOSITION OF THE PHARMACY CONTAINED
ID17810A (en) NEW SUBSTITUTED 2,4-TIAZOLIDINDION DOCUMENTS, PROCESSES FOR THE PRODUCTION AND PHARMACY COMPOSITION WHICH CONTAINS IT
ID25516A (en) COMPOUNDS CONTAINING SIX-RING RINGS, THE PROCESS OF MAKING IT, AND USING IT AS A MEDICINE
ID20137A (en) PROPANOLAMINA DECREASED, THE PROCESS OF MAKING, PHARMACEUTICAL PROPERTIES THAT CONTAIN THIS COMPOUND, AND ITS USE
ID24714A (en) SUBSTITUTION OF TIAZOLIDINDION DERIVATES, THE PROCESS OF PRODUCTION AND USE OF THE PHARMACEUTICAL MATERIALS
ID24070A (en) THE CATALYST CONTAINING HOLOGIST AND THE PROCESS OF MAKING IT
ID24600A (en) THE PROCESS FOR MAKING POLYETERS AND POLYOLS WHICH MADE TOGETHER
EP0968156A4 (en) Gas generant compositions, methods of production of the same and devices made therefrom
ID17076A (en) 2,4-DISUBSTITUTION OF PYRIMIDINE, THE PROCESS FOR MAKING THE SAME SUBSTANCE AND PHARMACY COMPOSITION CONTAINING THE SAME SUBSTANCE
ID24173A (en) 1,2,3,4,5,6 HEKSAHIDRO-2-6-METANO-3-BENZAZOSIN-10-OL, THE PROCESS OF MAKING AND USING IT FOR MEDICINES
ID16824A (en) NEW CARBOXICATE ACID DECLARATIONS, MANUFACTURE AND USE OF IT